Humana Cuts 2026 Profit Outlook After Medicare Star Ratings Decline
Health insurer Humana has revised its 2026 profit forecast downward due to lower star ratings for its Medicare plans, which the company said will lead to reduced federal payments. Humana's Medicare Advantage plans saw a decline in star scores under the government's quality assessment. These scores directly affect premium payments and bonuses to insurers. The lower ratings will negatively impact the company's revenue in 2026. In its updated financial outlook, Humana lowered its earnings per share expectations for 2026 below previous estimates. Management attributed the decline largely to the change in Medicare ratings and said it would seek to partially offset the impact through operational improvements. Analysts noted that the pressure on Humana's profit margins reflects broader regulatory changes affecting Medicare Advantage plans across the industry. The company announced it will focus on cost control and improving member health outcomes in the coming period. This is not investment advice.
📊 HUM — Piyasa Yorumu
▼ down · 70%The news indicates that Humana has lowered its 2026 profit expectations due to a decline in its Medicare Star Ratings. This could be perceived as a negative signal for the company's future profitability. Although technical indicators show the RSI just above 50 and the MACD in negative territory, the price trading above the SMA20 suggests potential for a short-term recovery. However, the negative sentiment generated by the news may override these technical signals. Therefore, a downward movement is expected in the short term.
RSI 14
52.0
MACD
-2.17
24h Δ
-0.35%
Canlı Grafikler
🔗 İlgili haberler
⭐ 67 · 15.07
Elevance Gelirleri Sağlık Sigortası Hisselerini Olumsuz Etkiledi; UNH Sırada
⭐ 75 · 29.06
İsveçli bakım şirketi Ambea, Humana için 304 milyon dolarlık tavsiye edilen teklif sundu
⭐ 67 · 04.06
Sağlık Sigortası Şirketlerinde Tıbbi Maliyetlerdeki Yumuşama Analistleri Sevindirdi
⭐ 67 · 26.05
Humana Hisseleri Medicare Advantage Oranının Beklentileri Karşılamamasıyla Geriledi
⭐ 67 · 13.05
Piper Sandler, Humana Hedef Fiyatını 254 Dolara Yükseltti: Medicare Advantage Gücü Boğa Senaryosunu Destekliyor
⭐ 79 · 10.04
Oscar Health Hisse Değişimi: Medicare Ödeme Artışıyla %12,88'lik Artış
🧬 Buna benzer
⭐ 67
Humana Hisseleri Medicare Advantage Oranının Beklentileri Karşılamamasıyla Geriledi
⭐ 75
İsveçli bakım şirketi Ambea, Humana için 304 milyon dolarlık tavsiye edilen teklif sundu
⭐ 67
Tesla'nın Satış Artışı, Optimus ve Robotaxi Yatırımları İçin Daha Fazla Nakit Gerektiriyor: 2. Çeyrek Kazanç Ön İzlemesi
⭐ 72
Anthropic İlk Çeyrek Kârına Yaklaşıyor, SpaceX'e Aylık 1.25 Milyar Dolar Ödüyor
AI tarafından yeniden derlenmiştir. Yatırım tavsiyesi değildir.